Since its inception in 2018, SMAS Technology Co., Ltd. has specialized in the printing of glucose test strips. Driven by a commitment to excellence, we continuously refine our processes to deliver products that meet the highest standards of stability and consistency, exceeding even the most stringent customer requirements.
In 2022,SMAS became a proud subsidiary of the Yao Sheng Group. That same year, we demonstrated our R&D strength by securing a patent for safety syringes and investing strategically in new ventures. To support our expansion and commitment to sustainability, we relocated to a state-of-the-art manufacturing facility in Daxi. This modern plant, spanning over 1,000 square meters and equipped with four advanced production lines, is dedicated to establishing a comprehensive safety syringe production chain. As Taiwan’s only manufacturer equipped with Japanese tri-bevel needle grinding technology, we continue to push the boundaries of innovation, enhancing our production processes and planning for fully automated syringe assembly lines. Our goal is to provide a complete MIT (Made in Taiwan) solution for safe syringe development, from R&D to production, ensuring the highest standards of safety for healthcare professionals.
Our high-safety syringes are designed with medical personnel in mind, prioritizing user experience and safety. These products significantly reduce the risks of cross-infection and lower medical waste disposal costs, reflecting our commitment to advancing global healthcare.
At SMAS, quality is more than a priority—it’s our guiding principle. We have achieved several authoritative certifications, including ISO13485, QMS, and TFDA, supported by a rigorous quality management system. By leveraging cutting-edge equipment, advanced techniques, and a team of industry-leading professionals, we deliver superior products and forge strong, win-win partnerships with our clients.
In 2025, SMAS entered into a strategic alliance with DA-YI BIOMEDICAL, appointing DA-YI as its exclusive distributor across Taiwan. Together, the two companies are committed to delivering high-quality medical solutions directly to frontline clinical environments. Leveraging DA-YI’s deep expertise and market insight in healthcare alongside SMAS’s strong R&D capabilities, this partnership creates a powerful strategic synergy: SMAS focuses on precision engineering, while specializes in professional clinical services.
DA-YI serves not only as a promoter of medical products, but also as a critical bridge between technology and clinical practice. The company is responsible for comprehensive market deployment, logistics, and after-sales support. Through this strong collaboration between manufacturing and distribution, MIT-quality protective solutions are transformed into trusted tools in the hands of healthcare professionals—together building a robust safeguard for Taiwan’s medical system.
Guided by this shared vision, DA-YI is dedicated to protecting the safety of healthcare workers, with the mission of making “zero needle-stick injuries” a standard in medical environments. At the same time, DA-YI remains committed to advancing the sustainable adoption of high-quality domestically produced medical devices, fulfilling its corporate social responsibility and creating long-term value for the future of Taiwan’s healthcare ecosystem.br />
Looking ahead, SMAS remains dedicated to strengthening its roots in Taiwan while expanding into international markets. Building on our expertise in medical devices, we are actively exploring opportunities in smart energy and energy conservation sectors. Through technological innovation and cross-disciplinary collaboration, we aim to drive societal progress and contribute to a sustainable future.